Autolus Therapeutics (AUTL) Misses Q2 EPS by 3c

Autolus Therapeutics (NASDAQ: AUTL) reported Q2 EPS of ($0.22), $0.03 worse than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Qualcomm (QCOM) Is Said To Near Deal For Ai Chip Startup Modular - Bloomberg
• Edgewell stock surges on report of rejected takeover bid